The alpha lipoic acid market is projected to grow to $1.4 billion by 2030, driven by demand in pharmaceuticals and cosmetics, with North America leading.
Allied Market Research published a report, titled, “Alpha Lipoic Acid Market by Product Type (R Alpha Lipoic Acid and S Alpha Lipoic Acid) and Application (Dietary Supplements, Cosmetics, Pharmaceuticals, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the report, the global alpha lipoic acid industry generated $0.7 billion in 2020, and is anticipated to generate $1.4 billion by 2030, witnessing a CAGR of 6.3% from 2021 to 2030.
Prime determinants of growth
Robust dietary supplements demand and rise in demand for anti-aging creams drive the growth of the global alpha lipoic acid market. However, side-effects associated with the use of alpha-lipoic acid hinder the market growth. On the other hand, surge in utilization for nerve pain treatment in people with diabetes presents new opportunities in the coming years.
Get | Download Sample Copy with TOC, Graphs & List of Figures@ https://www.alliedmarketresearch.com/request-sample/14070
Covid-19 Scenario
The R alpha lipoic acid segment to maintain its leadership status throughout the forecast period
Based on product type, the R alpha lipoic acid segment held the highest market share in 2020, accounting for four-fifths of the global alpha lipoic acid market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 6.6% from 2021 to 2030. The increasing energy-dense diet and physical inactivity have surged the number of diabetic patients where r alpha-lipoic acid is widely used in neuropathy treatment for reducing pain, numbness, and paresthesia. This is turn, is acting as one of the key drivers responsible for market growth. Another segment discussed in the report is S alpha lipoic acid.
Get | Detailed COVID-19 Impact Analysis on the Alpha Lipoic Acid Market @ https://www.alliedmarketresearch.com/request-for-customization/14070?reqfor=covid
The pharmaceuticals segment to maintain its lead position during the forecast period
Based on application, the pharmaceuticals segment accounted for the largest share in 2020, contributing more than two-fifths of the global alpha lipoic acid market, and is projected to maintain its lead position during the forecast period. This is due the rapid change in lifestyle and energy-dense diet. Moreover, this segment is also expected to portray the largest CAGR of 6.8% from 2021 to 2030, while the dietary supplements segment is expected to have CAGR of 6.1% from 2021 to 2030.
North America to maintain its dominance by 2030
Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than one-third of the global alpha lipoic acid market. However, the Asia-Pacific region is expected to witness the fastest CAGR of 7.4% from 2021 to 2030, owing to the utilization of alpha-lipoic acid in sectors such as cosmetics, pharmaceuticals, and others.
Leading Market Players:
Interested in Procuring This Report? Visit Here:
https://www.alliedmarketresearch.com/alpha-lipoic-acid-market/purchase-options
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
The article focuses on the alpha lipoic acid market, its growth prospects, and key industry drivers.
The market is expected to grow from $0.7 billion in 2020 to $1.4 billion by 2030, with a CAGR of 6.3%.
Robust demand for dietary supplements and anti-aging creams are key drivers, along with opportunities in nerve pain treatment.
Explore more articles in the Research Reports category
